It is a pharma foreign private limited company based in Mumbai, Maharashtra, India, established in 2021.
2021 | Mumbai, Maharashtra, India | ActiveGaronit Pharmaceuticals Private Limited, a active foreign private limited company, was established on 11 February 2021 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290MH2021FTC355132. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹1.00 Cr.
Its leadership includes Rohit Shamlal Garg (Director), Sanket Dhondiraj Sawant (Additional Director), Nitin Sham Lal Garg (Director). Past directors included Vikram Vyas, Rohit Shamlal Garg. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-305, Vip Plaza, Off Link Road, Andheri West, Veera Desai R, Opp. Infinity Mall,, Mumbai, Maharashtra, 400053.
U24290MH2021FTC355132
355132
11 February 2021
₹25.00 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Garonit Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Shamlal Garg | Director | 22 Feb 2022 | Current |
| Sanket Dhondiraj Sawant | Additional Director | 24 Dec 2024 | Current |
| Nitin Sham Lal Garg | Director | 11 Feb 2021 | Current |
| Darshan Harish Bhawsar | Director | 05 Mar 2025 | Current |
| Vijay Nilkanth Koyande | Additional Director | 29 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Dec 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Garonit Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Garonit Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Garonit Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Garonit Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Garonit Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Garonit Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Vijay Nilkanth Koyande was appointed as a Additional Director was appointed as a Additional Director on 29 Sep 2025 & has been associated with this company since 3 months . was documented.
Progress on Garonit Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on Darshan Harish Bhawsar was appointed as a Director was appointed as a Director on 05 Mar 2025 & has been associated with this company since 9 months 25 days . was documented.
Sanket Dhondiraj Sawant was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2024 & has been associated with this company since 1 year 4 days . was recorded as a recent event.
Progress on Rohit Shamlal Garg was appointed as a Director was appointed as a Director on 22 Feb 2022 & has been associated with this company since 3 years 10 months . was documented.
The CIN of Garonit Pharmaceuticals Private Limited is U24290MH2021FTC355132.
Garonit Pharmaceuticals Private Limited is headquartered at A-305, Vip Plaza, Off Link Road, Andheri West, Veera Desai R, Opp. Infinity Mall,, Mumbai, Maharashtra, 400053.
Garonit Pharmaceuticals Private Limited was incorporated on 11 February 2021.
The current directors of Garonit Pharmaceuticals Private Limited are
The primary industry of Garonit Pharmaceuticals Private Limited is Pharma.
Garonit Pharmaceuticals Private Limited is unlisted.
The authorized capital of Garonit Pharmaceuticals Private Limited is ₹25.00 Cr, and the paid-up capital is ₹1.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX